In newly diagnosed patients 75 years or older, or who have comorbidities that preclude the

use of intensive induction chemotherapy.

*

INQOVI + venetoclax is 

NOW APPROVED

for acute myeloid leukemia (AML)¹*

NOW APPROVED

Illustrative only.

Not actual size.

INQOVI tablets

contain decitabine

and cedazuridine.

combination regimen for adults with newly diagnosed AML^1,2

ORAL

ALL-

The only

SEE THE DATA IN AML